A highly enantioselective abiotic receptor for malate dianion in aqueous solution

The highly enantioselective molecular recognition of the malate dianion by a synthetic receptor in aqueous solution has been studied by potentiometric titrations, mass spectrometry (ESI-MS), diffusion measurements (PGSE NMR) and molecular modeling.Garcia-España Monsonis, Enrique, [email protected]

Storage of agricultural products in O Castelo de Laias (Cenlle, Ourense). Conservation and consumption strategies

The hillfort of O Castelo de Laias, next to the Miño River, has provided an extended sequence of occupation, from Late Bronze Age-1st Iron Age, to a Roman Early Imperial phase. In the upper enclosure of the castro a singular ensemble of structures for the storage of agricultural products was found, dating from the 4th and 3rd centuries BC. This enclosure had a monumental wall and its surface was prepared with terraces to place the granaries, while the houses spread out on the slope. In this paper it is proposed a systematization of data on the construction and features of the grain-containers and of the stored products, basically cereals, as well as a social interpretation, taking into account the storage capacity and the composition of what was stored in each container.El asentamiento de O Castelo de Laias, junto al río Miño, ha proporcionado una larga secuencia de ocupación, desde la Edad del Bronce Final-Primera Edad del Hierro hasta una fase altoimperial romana. El recinto superior del castro conserva un singular conjunto de estructuras para el almacenamiento de productos agrarios, datadas en los ss. IV y III a. C. Este recinto fue amurallado y su superficie acondicionada mediante bancales, para permitir la instalación de los graneros, mientras las viviendas se extendieron por la ladera. En este artículo, se propone una sistematización de los datos sobre la construcción y características de los contenedores; los productos almacenados, básicamente cereales, y una interpretación en clave social, teniendo en cuenta la capacidad de almacenamiento y la composición de lo almacenado en cada depósito

Endogenous topoisomerase II-mediated DNA breaks drive thymic cancer predisposition linked to ATM deficiency

The ATM kinase is a master regulator of the DNA damage response to double-strand breaks (DSBs) and a well-established tumour suppressor whose loss is the cause of the neurodegenerative and cancer-prone syndrome Ataxia-Telangiectasia (A-T). A-T patients and Atm−/− mouse models are particularly predisposed to develop lymphoid cancers derived from deficient repair of RAG-induced DSBs during V(D)J recombination. Here, we unexpectedly find that specifically disturbing the repair of DSBs produced by DNA topoisomerase II (TOP2) by genetically removing the highly specialised repair enzyme TDP2 increases the incidence of thymic tumours in Atm−/− mice. Furthermore, we find that TOP2 strongly colocalizes with RAG, both genome-wide and at V(D)J recombination sites, resulting in an increased endogenous chromosomal fragility of these regions. Thus, our findings demonstrate a strong causal relationship between endogenous TOP2-induced DSBs and cancer development, confirming these lesions as major drivers of ATM-deficient lymphoid malignancies, and potentially other conditions and cancer types.Junta de Andalucía SAF2010-21017, SAF2013-47343-P, SAF2014-55532-R, SAF2017-89619-R, CVI-7948European Research Council ERC-CoG-2014-64735

Toxoptera citricida (Kirkaldy) (Hemiptera, Aphididae) and its natural enemies in Spain

The aphid Toxoptera citricida (Kirkaldy) is the most efficient vector of Citrus tristeza virus (CTV) in the world, and it can transmit the more aggressive isolates of CTV. T. citricida is present in most of the zones growing citrus in the world, but it was absent from the Mediterranean Basin and North America until middle 1990’s. Nevertheless, it was detected on citrus trees in 1994 in Madeira, in 1995 in Florida, in 2002 in Asturias, Spain (in yellow water traps), in 2003 in northern mainland Portugal, and in 2004 in southern Galicia, Spain, even though the three last detections were not published till 2005. As a consequence of its detection in Spain, several surveys and studies were undertaken from 2005. The main results are listed below. Currently, T. citricida is present on citrus along the Atlantic coast in the northwest quadrant of the Iberian Peninsula. In Asturias, it presents a minimum in winter and other one in summer, but the last one is shorter than the minimum which Mediterranean citrus aphids have too. Chaenomeles speciosa (Rosaceae) has been found as an occasional alternative host for T. citricida. No winter eggs of T. citricida have been seen. CTV spread has not been detected in northern Spain. T. citricida is attacked in the Atlantic area by several natural enemy species, most of them present in the Mediterranean zone

Study of risk factors for healthcare-associated infections in acute cardiac patients using categorical principal component analysis (CATPCA)

Epidemiology; Preventive medicineEpidemiologia, Medicina preventivaEpidemiología; Medicina preventivaUsing categorical principal component analysis, we aimed to determine the relationship between health care-associated infections (HAIs) and diagnostic categories (DCs) in patients with acute heart disease using data collected in the Spanish prospective ENVIN-HELICS intensive care registry over a 10-year period (2005–2015). A total of 69,876 admissions were included, of which 5597 developed HAIs. Two 2-component CATPCA models were developed. In the first model, all cases were included; the first component was determined by the duration of the invasive devices, the ICU stay, the APACHE II score and the HAIs; the second component was determined by the type of admission (medical or surgical) and by the DCs. No clear association between DCs and HAIs was found. Cronbach’s alpha was 0.899, and the variance accounted for (VAF) was 52.5%. The second model included only admissions that developed HAIs; the first component was determined by the duration of the invasive devices and the ICU stay; the second component was determined by the inflammatory response, the mortality in the ICU and the HAIs. Cronbach’s alpha value was 0.855, and VAF was 46.9%. These findings highlight the role of exposure to invasive devices in the development of HAIS in patients with acute heart disease

Guía de intervención policial con personas con discapacidad intelectual

Esta guía permitirá a las Fuerzas y Cuerpos de Seguridad del Estado adaptar sus procedimientos cuando una persona con discapacidad intelectual forme parte de la investigación policial. Ofrece un marco conceptual para entender la discapacidad intelectual y herramientas específicas para adecuar la comunicación y dotar de los apoyos necesarios a estas personas. Así mismo, propone un ajuste específico tanto en las entrevistas como en las ruedas de reconocimiento realizadas a personas con discapacidad intelectual. Su aplicación garantizará que la intervención policial se efectúe conforme a la Convención de Derechos de las Personas con Discapacidad de Naciones Unidas

New, Fully Implantable Device for Selective Clearance of CSF-Target Molecules: Proof of Concept in a Murine Model of Alzheimer’s Disease

[EN] We have previously proposed a radical change in the current strategy to clear pathogenic proteins from the central nervous system (CNS) based on the cerebrospinal fluid (CSF)-sink therapeutic strategy, whereby pathogenic proteins can be removed directly from the CNS via CSF. To this aim, we designed and manufactured an implantable device for selective and continuous apheresis of CSF enabling, in combination with anti-amyloid-beta (Aβ) monoclonal antibodies (mAb), the clearance of Aβ from the CSF. Here, we provide the first proof of concept in the APP/PS1 mouse model of Alzheimer’s disease (AD). Devices were implanted in twenty-four mice (seventeen APP/PS1 and seven Wt) with low rates of complications. We confirmed that the apheresis module is permeable to the Aβ peptide and impermeable to mAb. Moreover, our results showed that continuous clearance of soluble Aβ from the CSF for a few weeks decreases cortical Aβ plaques. Thus, we conclude that this intervention is feasible and may provide important advantages in terms of safety and efficacy.This work was supported by the Instituto de Salud Carlos III, under Grant DTS19-00071 to M.M.-G. and by the Fundación para el Fomento en Asturias de la Investigación Científica Aplicada y la Tecnología (FICYT), under Grant AYUD/2021/57540, to C.T.-Z

Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications

Recent studies have found the KIT D816V mutation in peripheral blood of virtually all adult systemic mastocytosis patients once highly sensitive PCR techniques were used; thus, detection of the KIT D816V mutation in peripheral blood has been proposed to be included in the diagnostic work-up of systemic mastocytosis algorithms. However, the precise frequency of the mutation, the biological significance of peripheral blood-mutated cells and their potential association with involvement of bone marrow hematopoietic cells other than mast cells still remain to be investigated. Here, we determined the frequency of peripheral blood involvement by the KIT D816V mutation, as assessed by two highly sensitive PCR methods, and investigated its relationship with multilineage involvement of bone marrow hematopoiesis. Overall, our results confirmed the presence of the KIT D816V mutation in peripheral blood of most systemic mastocytosis cases (161/190; 85%)-with an increasing frequency from indolent systemic mastocytosis without skin lesions (29/44; 66%) to indolent systemic mastocytosis with skin involvement (124/135; 92%), and more aggressive disease subtypes (11/11; 100%)-as assessed by the allele-specific oligonucleotide-qPCR method, which was more sensitive (P<.0001) than the peptide nucleic acid-mediated PCR approach (84/190; 44%). Although the presence of the KIT mutation in peripheral blood, as assessed by the allele-specific oligonucleotide-qPCR technique, did not accurately predict for multilineage bone marrow involvement of hematopoiesis, the allele-specific oligonucleotide-qPCR allele burden and the peptide nucleic acid-mediated-PCR approach did. These results suggest that both methods provide clinically useful and complementary information through the identification and/or quantification of the KIT D816V mutation in peripheral blood of patients suspected of systemic mastocytosis.This work was supported in part by grants from the Fondo de Investigaciones Sanitarias (FIS; grant number PI11/02399, FEDER) and Red Temática de Investigación Cooperativa en Cancer (RTICC; grant number RD12/0036/0048, FEDER) of the Instituto deSalud Carlos III (Ministry of Economy and Competitivity, Madrid, Spain), from Fundacion Ramon Areces (Madrid, Spain; grant number CIVP16A1806) and from Ayudas a Proyectos de Investigación en Salud de la Fundación Mutua Madrileña 2014 and Asociación Española de Enfermos de Mastocitosis (AEDM 2014). The National DNA Bank is supported by grants from the Instituto de Salud Carlos III of the Ministerio de Economia y Competitividad of Spain (grand numbers PT13/0001/0037 and PT13/0010/ 0067, FEDER). AM was supported by RTICC.Peer Reviewe

KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes

[Background]: Current diagnostic algorithms for systemic mastocytosis (SM) rely on the detection of KITD816V in blood to trigger subsequent bone marrow (BM) investigations. [Methods]: Here, we correlated the KITD816V mutational status of paired blood and BM samples from 368 adults diagnosed with mast cell activation syndrome (MCAS) and mastocytosis and determined the potential utility of investigating KITD816V in genomic DNA from blood-purified myeloid cell populations to increase diagnostic sensitivity. In a subset of 69 patients, we further evaluated the kinetics of the KITD816V cell burden during follow-up and its association with disease outcome. [Results]: Our results showed a high correlation (P < .0001) between the KITD816V mutation burden in blood and BM (74% concordant samples), but with a lower mean of KITD816V-mutated cells in blood (P = .0004) and a high rate of discordant BM+/blood− samples particularly among clonal MCAS (73%) and BM mastocytosis (51%), but also in cutaneous mastocytosis (9%), indolent SM (15%), and well-differentiated variants of indolent SM (7%). Purification of different compartments of blood-derived myeloid cells was done in 28 patients who were BM mast cell (MC)+/blood− for KITD816V, revealing KITD816V-mutated eosinophils (56%), basophils (25%), neutrophils (29%), and/or monocytes (31%) in most (61%) patients. Prognostically, the presence of ≥3.5% KITD816V-mutated cells (P < .0001) and an unstable KITD816V mutation cell burden (P < .0001) in blood and/or BM were both associated with a significantly shortened progression-free survival (PFS). [Conclusions]: These results confirm the high specificity but limited sensitivity of KITD816V analysis in whole blood for the diagnostic screening of SM and other primary MCAS, which might be overcome by assessing the mutation in blood-purified myeloid cell populations.This work was supported by grants from the Fundación Española de Mastocitosis (Madrid, Spain; grant number: FEM2021-SAM) and Blueprint Medicines Corporation (Cambridge, MA). PNN was supported by a grant of Government of Castilla y León (Orden EDU 875 2021), Spain; co-financed with the European Social Fund (BDNS (Identif.): 540787). We also thank the Agencia Estatal de Investigación (AEI) and European Regional Development Fund (FEDER) for the grant (EQC2019-005419-P) within the Subprograma Estatal de Infraestructuras de Investigación y Equipamiento Científico Técnico de 2019